I-Corps: Portable Autonomous Biomarker Sampling Technology (PABST)

I-Corps：便携式自主生物标志物采样技术 (PABST)

• 批准号: 1608747
• 负责人: David Fries
• 金额: $ 5万
• 依托单位: University of South Florida
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-12-01 至 2016-11-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1608747&HistoricalAwards=false
• 关键词: Corps; Portable; Autonomous; Biomarker; Sampling

Chemistry in our bodies is the next frontier for medical diagnostics and testing. Current medical testing of patients for their health is dominated by infrequent testing out of the home (i.e. at the hospital or doctor's office). This under-sampling paradigm which has dominated healthcare diagnostics has led to a persistent bias in fully understanding patient wellness. A patient "weather report" cannot be done without sufficient knowledge of the changes of the patient's internal chemistry and how that chemistry is changing due to environmental stress, drug therapy or other treatments on a patient after they leave the hospital. Testing at the doctor's office or clinic yields minimal insight into variability of a patient throughout the day or over the week. This I-Corps team has devised a Portable Biomarker Autonomous Sampling Technology that can be attached to a toilet to create an intelligent non-invasive sampling system for urine biomarkers in the home. The biomarkers captured from urine over the course of some prescribed period are shipped to a lab for analytical testing and the biochemical history of the patient can be then understood to a level of detail never before allowed in the healthcare industry. Doctors will have a powerful tool to chart a person's physical well-being. The technology was originally developed for ocean observations to gain understanding of the spatial and temporal change of the chemistry and biology of the oceans and now can be applied to measuring human health changes and responses.The goal of the project is to advance both the product and the business potential of the proposed diagnostic innovation which is a portable biomarker robotic sampler for in-the-home use for biomarker sampling in urine. Samples from the home can be coupled to clinical laboratory-based biomarker testing to allow for high frequency, precision medicine and personal observations of a patient for the first time. An expected outcome of this project is the customer-discovery guided development of a commercialization plan for the Biomarker Sampler products and services. The I-Corps team expects to also include collaborative demonstrations using the automation system with potential customers, third party vendors, and outside manufacturers to validate and enhance the effectiveness of the current sampler design. Engineering design changes will occur based on customer feedback and demo-testing results. In parallel, the team will research the current and future markets for the in-home automation system, its distribution channels, and potential partnership opportunities. Based on the outcomes of the team's development, the team will determine the appropriate business strategy to move the automation system to market. At the end of the project, the team expects to have a scalable automation core that effectively enables automated quantitative sampling of key biomarkers ready for analysis in the laboratory to allow for unique, industry changing "patient weather" reporting.

我们体内的化学是医学诊断和测试的下一个前沿。目前，对患者的健康状况进行的医学检测主要是在家中（即在医院或医生办公室）进行的不频繁的检测。这种占主导地位的医疗诊断抽样不足的范式导致了在充分了解患者健康方面的持续偏见。在没有足够的关于患者的内部化学变化的知识的情况下，以及在患者离开医院后，由于环境压力、药物治疗或对患者的其他治疗，该化学如何变化，就不能完成患者的“天气报告”。在医生办公室或诊所进行的测试对患者在一天或一周内的变化性的了解很少。这个I-Corps团队设计了一种便携式生物标志物自主采样技术，可以连接到马桶上，为家中的尿液生物标志物创建一个智能的非侵入性采样系统。在规定的时间内从尿液中捕获的生物标志物被运送到实验室进行分析测试，然后可以了解患者的生化史，其详细程度在医疗保健行业前所未有。 医生将有一个强大的工具来绘制一个人的身体健康。该技术最初是为海洋观测而开发的，目的是了解海洋化学和生物学的时空变化，现在可以应用于测量人类健康变化和反应。该项目的目标是推进拟议的诊断创新的产品和商业潜力，这是一种便携式生物标志物机器人采样器，可在家中用于尿液中的生物标志物采样。 来自家庭的样本可以与基于临床实验室的生物标志物检测相结合，从而首次实现对患者的高频率、精确医学和个人观察。 该项目的预期成果是以客户发现为导向，制定生物标志物采样器产品和服务的商业化计划。 I-Corps团队还希望与潜在客户、第三方供应商和外部制造商一起使用自动化系统进行协作演示，以验证和提高当前采样器设计的有效性。工程设计变更将根据客户反馈和演示测试结果进行。与此同时，该团队将研究家庭自动化系统的当前和未来市场，其分销渠道以及潜在的合作机会。根据团队的开发成果，团队将确定将自动化系统推向市场的适当业务策略。在项目结束时，该团队预计将拥有一个可扩展的自动化核心，有效地实现关键生物标志物的自动定量采样，以便在实验室中进行分析，从而实现独特的、改变行业的“患者天气”报告。